Matsuo M - Search Results

1

Evaluation of Suspected Autosomal Alport Syndrome Synonymous Variants.

Rossanti R, Horinouchi T, Yamamura T, Nagano C, Sakakibara N, Ishiko S, Aoto Y, Kondo A, Nagai S, Okada E, Ishimori S, Nagase H, Matsui S, Tamagaki K, Ubara Y, Nagahama M, Shima Y, Nakanishi K, Ninchoji T, Matsuo M, Iijima K, Nozu K. Rossanti R, et al. Among authors: matsuo m. Kidney360. 2021 Oct 13;3(3):497-505. doi: 10.34067/KID.0005252021. eCollection 2022 Mar 31. Kidney360. 2021. PMID: 35582193 Free PMC article.

2

Blockade of TGF-beta action ameliorates renal dysfunction and histologic progression in anti-GBM nephritis.

Zhou A, Ueno H, Shimomura M, Tanaka R, Shirakawa T, Nakamura H, Matsuo M, Iijima K. Zhou A, et al. Among authors: matsuo m. Kidney Int. 2003 Jul;64(1):92-101. doi: 10.1046/j.1523-1755.2003.00045.x. Kidney Int. 2003. PMID: 12787399 Free article.

3

Role of p38 MAP kinase pathway in a toxin-induced model of hemolytic uremic syndrome.

Fu XJ, Iijima K, Nozu K, Hamahira K, Tanaka R, Oda T, Yoshikawa N, Matsuo M. Fu XJ, et al. Among authors: matsuo m. Pediatr Nephrol. 2004 Aug;19(8):844-52. doi: 10.1007/s00467-004-1502-4. Epub 2004 Jun 17. Pediatr Nephrol. 2004. PMID: 15206036

4

Cyclosporin A absorption profiles in children with nephrotic syndrome.

Nozu K, Iijima K, Sakaeda T, Okumura K, Nakanishi K, Yoshikawa N, Honda M, Ikeda M, Matsuo M. Nozu K, et al. Among authors: matsuo m. Pediatr Nephrol. 2005 Jul;20(7):910-3. doi: 10.1007/s00467-005-1844-6. Epub 2005 Apr 23. Pediatr Nephrol. 2005. PMID: 15856324

5

Rituximab treatment for posttransplant lymphoproliferative disorder (PTLD) induces complete remission of recurrent nephrotic syndrome.

Nozu K, Iijima K, Fujisawa M, Nakagawa A, Yoshikawa N, Matsuo M. Nozu K, et al. Among authors: matsuo m. Pediatr Nephrol. 2005 Nov;20(11):1660-3. doi: 10.1007/s00467-005-2013-7. Epub 2005 Aug 16. Pediatr Nephrol. 2005. PMID: 16133051

6

Long-term follow-up of atypical membranoproliferative glomerulonephritis: are steroids indicated?

Fujita T, Nozu K, Iijima K, Kamioka I, Yoshiya K, Tanaka R, Hamahira K, Nakanishi K, Yoshikawa N, Matsuo M. Fujita T, et al. Among authors: matsuo m. Pediatr Nephrol. 2006 Feb;21(2):194-200. doi: 10.1007/s00467-005-2074-7. Epub 2005 Oct 25. Pediatr Nephrol. 2006. PMID: 16247645

7

High-dose mizoribine treatment for adolescents with systemic lupus erythematosus.

Nozu K, Iijima K, Kamioka I, Fujita T, Yoshiya K, Tanaka R, Nakanishi K, Yoshikawa N, Matsuo M. Nozu K, et al. Among authors: matsuo m. Pediatr Int. 2006 Apr;48(2):152-7. doi: 10.1111/j.1442-200X.2006.02178.x. Pediatr Int. 2006. PMID: 16635174

8

Enamel-renal syndrome associated with hypokalaemic metabolic alkalosis and impaired renal concentration: a novel syndrome?

Fu XJ, Nozu K, Goji K, Ikeda K, Kamioka I, Fujita T, Kaito H, Nishio H, Iijima K, Matsuo M. Fu XJ, et al. Among authors: matsuo m. Nephrol Dial Transplant. 2006 Oct;21(10):2959-62. doi: 10.1093/ndt/gfl328. Epub 2006 Jun 24. Nephrol Dial Transplant. 2006. PMID: 16799168 No abstract available.

9

Prediction of systemic exposure to cyclosporine in Japanese pediatric patients.

Sakaeda T, Iijima K, Nozu K, Nakamura T, Moriya Y, Nishikawa M, Wada A, Okamura N, Matsuo M, Okumura K. Sakaeda T, et al. Among authors: matsuo m. J Hum Genet. 2006;51(11):969-976. doi: 10.1007/s10038-006-0048-7. Epub 2006 Sep 14. J Hum Genet. 2006. PMID: 16972021

10

The effect of aldosterone blockade in patients with Alport syndrome.

Kaito H, Nozu K, Iijima K, Nakanishi K, Yoshiya K, Kanda K, Przybyslaw Krol R, Yoshikawa N, Matsuo M. Kaito H, et al. Among authors: matsuo m. Pediatr Nephrol. 2006 Dec;21(12):1824-9. doi: 10.1007/s00467-006-0270-8. Epub 2006 Oct 13. Pediatr Nephrol. 2006. PMID: 17039334

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,080 results

Search Page